Payments to Acquire Property, Plant, and Equipment of Emergent BioSolutions Inc. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Emergent BioSolutions Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • Emergent BioSolutions Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $3,600,000, a 67% decline year-over-year.
  • Emergent BioSolutions Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $13,800,000, a 40% decline from 2024.
  • Emergent BioSolutions Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $22,900,000, a 56% decline from 2023.
  • Emergent BioSolutions Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $51,600,000, a 55% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Emergent BioSolutions Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $13,800,000 -$9,100,000 -40% 01 Jan 2025 31 Dec 2025 10-K 27 Feb 2026 2025 FY
2024 $22,900,000 -$28,700,000 -56% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2026 2025 FY
2023 $51,600,000 -$64,200,000 -55% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2026 2025 FY
2022 $115,800,000 -$108,300,000 -48% 01 Jan 2022 31 Dec 2022 10-K 04 Mar 2025 2024 FY
2021 $224,100,000 +$82,200,000 +58% 01 Jan 2021 31 Dec 2021 10-K 08 Mar 2024 2023 FY
2020 $141,900,000 +$55,000,000 +63% 01 Jan 2020 31 Dec 2020 10-K/A 11 Dec 2023 2022 FY
2019 $86,900,000 +$14,800,000 +21% 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2022 2021 FY
2018 $72,100,000 +$17,300,000 +32% 01 Jan 2018 31 Dec 2018 10-K 19 Feb 2021 2020 FY
2017 $54,800,000 -$21,400,000 -28% 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020 2019 FY
2016 $76,200,000 +$31,388,000 +70% 01 Jan 2016 31 Dec 2016 10-K 22 Feb 2019 2018 FY
2015 $44,812,000 +$14,139,000 +46% 01 Jan 2015 31 Dec 2015 10-K 23 Feb 2018 2017 FY
2014 $30,673,000 -$11,348,000 -27% 01 Jan 2014 31 Dec 2014 10-K 28 Feb 2017 2016 FY
2013 $42,021,000 -$11,824,000 -22% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
2012 $53,845,000 -$181,000 -0.34% 01 Jan 2012 31 Dec 2012 10-K 09 Mar 2015 2014 FY
2011 $54,026,000 +$31,925,000 +144% 01 Jan 2011 31 Dec 2011 10-K 10 Mar 2014 2013 FY
2010 $22,101,000 01 Jan 2010 31 Dec 2010 10-K 08 Mar 2013 2012 FY

Emergent BioSolutions Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $3,600,000 -$7,200,000 -67% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $10,800,000 -$4,300,000 -28% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $15,100,000 -$17,100,000 -53% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q1 2022 $32,200,000 -$23,900,000 -43% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q1 2021 $56,100,000 +$31,900,000 +132% 01 Jan 2021 31 Mar 2021 10-Q 29 Apr 2022 2022 Q1
Q1 2020 $24,200,000 +$2,800,000 +13% 01 Jan 2020 31 Mar 2020 10-Q 30 Apr 2021 2021 Q1
Q1 2019 $21,400,000 +$9,800,000 +84% 01 Jan 2019 31 Mar 2019 10-Q 01 May 2020 2020 Q1
Q1 2018 $11,600,000 -$8,704,000 -43% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q1 2017 $20,304,000 +$2,090,000 +11% 01 Jan 2017 31 Mar 2017 10-Q 04 May 2018 2018 Q1
Q1 2016 $18,214,000 +$9,132,000 +101% 01 Jan 2016 31 Mar 2016 10-Q 05 May 2017 2017 Q1
Q1 2015 $9,082,000 +$4,492,000 +98% 01 Jan 2015 31 Mar 2015 10-Q 06 May 2016 2016 Q1
Q1 2014 $4,590,000 -$3,089,000 -40% 01 Jan 2014 31 Mar 2014 10-Q 08 May 2015 2015 Q1
Q1 2013 $7,679,000 -$14,650,000 -66% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014 2014 Q1
Q1 2012 $22,329,000 +$13,897,000 +165% 01 Jan 2012 31 Mar 2012 10-Q 03 May 2013 2013 Q1
Q1 2011 $8,432,000 01 Jan 2011 31 Mar 2011 10-Q 04 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.